Refine by
Drug Discovery Equipment & Supplies
143 equipment items found
by:Alloy Therapeutics, Inc. based inLexington, MASSACHUSETTS (USA)
ATX-Gx™, our first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. There are three ways to access the ATX-Gx™ ...
Manufactured by:Verge Genomics based inSouth San Francisco, CALIFORNIA (USA)
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform. ...
by:EraCal Therapeutics Ltd. based inSchlieren, SWITZERLAND
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying novel mechanisms of actions and, consequently, are a prime choice to discover first-in-class ...
Manufactured by:Confo Therapeutics based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics is building a pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying ...
Manufactured by:3B Pharmaceuticals GmbH based inBerlin, GERMANY
Discovery and preclinical development of peptide drug candidates have been 3BP’s core competencies since the company’s inception. ...
Manufactured by:SEngine Precision Medicine based inSeattle, WASHINGTON (USA)
Guiding drug discovery with proprietary high throughput 3D patient cell technology and genomics will drastically increase the success of novel drug candidates and directly result in faster development at reduced costs. SEngine Precision Medicine’s innovative approach brings diagnostics, drug discovery and ...
Manufactured by:Orbit Discovery based inOxford, UNITED KINGDOM
Orbit presents DNA and peptide on the surface of a microbead. This allows for unbiased libraries and a tunable multivalent display that gives access to huge chemical diversity. Our display technology can deal with unnatural amino acids and complex peptide constraints. It can display a peptide via complex scaffolds and makes whole cell screening and functional hits possible. ...
by:Curemark based inRye Brook, NEW YORK (USA)
Patient-centered drug discovery is at the core of what we do at Curemark. We approach neurological disorders from a translational and innovative ...
Manufactured by:Ardigen based inKraków, POLAND
Bioinformatics Analysis & Drug Discovery in the era of Artificial Intelligence. The digital CRO team brings together scientists and engineers with diverse skill sets, ranging from biology and chemistry to statistics and machine learning. We work with both small startups and big pharmas to leverage digital power in order to enable the development of new ...
Manufactured by:PharmaBlock Sciences (Nanjing), Inc. based inNanjing, CHINA
Fragment Based Drug Discovery (FBDD) has been established as an efficient tool in search of more accessible drug-like chemical space. Our FBDD group has developed a unique and well-designed fragment library with superb structural novelty and diversity based on our building block collections. ...
by:Sibylla Biotech S.p.A. based inVerona, ITALY
In Silico: Identifying small molecules able to revolutionize drug discovery. The PPI-FIT technology allows the exploration of unique pharmacological targets represented by protein folding intermediates. This places Sibylla Biotech in the exclusive position of identifying hit/lead compounds with a mechanism of action never explored so far. ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
The human heart is a complex organ of distinct sub-structures, different tissue types and cellular architectures that work in a coordinated fashion to pump blood throughout the body (Figure 1). Tissue distribution, cellular composition and gene expression vary throughout the heart to match regional function. Such organ complexity is precisely why AnaBios offers a suite of anatomically ...
by:Healx Ltd. based inCambridge, UNITED KINGDOM
The world’s most efficient AI platform for rare disease drug discovery, supporting our teams and partners in our mission to advance new treatments towards the ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
By developing cardiomyocytes directly from patient-derived iPSCs, we create a non-invasive, personalized platform to directly observe the effects of drug therapies on heart ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. TruTCR is summarized in the figure ...
by:Valo Health, Inc. based inBoston, MASSACHUSETTS (USA)
Opal is the first end-to-end integrated drug discovery & development platform. Traditional, linear approaches to target discovery and drug development have created sub-optimized systems that are intrinsically disintegrated and ...
Manufactured by:InvivoSciences, Inc. (IVS) based inMadison, WISCONSIN (USA)
InvivoSciences (IVS) combines its human micro tissue technology and phenotypic assay platform with the systems biology approach to achieve rare disease modeling for its drug discovery. Our strip tissues are perfect for modeling muscle and connective tissue in micro-well plates. Since many rare diseases affect heart muscle and skeletal muscle as well as ...
Manufactured by:Galapagos NV based inMechelen, BELGIUM
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Our TCR-antigen discovery capabilities may inform the design and development of next-generation vaccines. Adaptive has validated hundreds of immunogenic antigens that can be selected to design differentiated vaccines. Our platform is also used to detect and track vaccine-induced antigen-specific T cell responses that correlate with efficacy and safety. Our antigen specificity ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Neutralizing antibodies defend healthy cells by interfering with the biological function of an invading virus. These antibodies may be used therapeutically to treat someone currently fighting the disease and provide passive immunity to people who have recently been exposed to ...